CreditReports.dk
HomeScreen companies

Nykode Therapeutics Denmark A/S Financials, key figures and credit report

CVR number: 42038660 Established 2021 Industry: 70 Activities of head offices and management consultancy
Company contact details
Gammel Lundtoftevej 1 E, 2800 Kongens Lyngby
Gross profit 31 839.0 kDKK FY 2025 -49.9% vs 2024
EBIT 2 244.3 kDKK FY 2025 +426.3% vs 2024
Net debt -4 653.5 kDKK FY 2025 +40.2% vs 2024
Quick ratio 1.8 FY 2025 -0.2 vs 2024

Company information

Official name
Nykode Therapeutics Denmark A/S
Personnel
11 persons
Established
2021
Company form
Limited company
Industry

Data sources and methodology

The information about Nykode Therapeutics Denmark A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Nykode Therapeutics Denmark A/S

Nykode Therapeutics Denmark A/S (CVR number: 4203866-0) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of 31.8 mDKK in 2025. The operating profit was 2244.3 kDKK, while net earnings were 1347.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was 12.6 %, which can be considered good but Return on Equity (ROE) was 21.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 44.1 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Nykode Therapeutics Denmark A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit10 590.5938 639.0452 927.6563 552.5131 839.00
EBIT762.522 612.563 833.27426.452 244.33
Net earnings578.081 895.432 484.51156.961 347.13
Shareholders equity total978.082 873.515 358.015 514.976 862.10
Balance sheet total (assets)10 953.6014 830.2120 504.3020 422.2515 551.49
Net debt-4 265.401 491.55-7 490.64-7 780.87-4 653.50
Profitability
EBIT-%
ROA7.1 %21.5 %21.8 %2.1 %12.6 %
ROE59.1 %98.4 %60.4 %2.9 %21.8 %
ROI11.8 %34.8 %40.6 %3.6 %18.5 %
Economic value added (EVA)590.101 698.042 511.56- 187.271 174.08
Solvency
Equity ratio8.9 %19.4 %26.1 %27.0 %44.1 %
Gearing576.9 %221.9 %26.6 %21.6 %
Relative net indebtedness %
Liquidity
Quick ratio1.02.61.32.01.8
Current ratio1.02.61.32.01.8
Cash and cash equivalents9 908.304 885.077 490.649 248.326 133.82
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
12.6%
Rating 62/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
44.1%
Rating 36/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Nykode Therapeutics Denmark A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated